(Q33750063)

29 July 2017

1 reference

title

Alpha-synuclein in Lewy body disease and Alzheimer's disease (English)

1 reference

29 July 2017

1 reference

2

Masliah E

1 reference

29 July 2017

Hashimoto M

1

1 reference

29 July 2017

1 October 1999

1 reference

29 July 2017

1 reference

29 July 2017

9

1 reference

29 July 2017

4

1 reference

29 July 2017

707-720

1 reference

Oxygen free radicals and Parkinson's disease

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Peripheral nervous system-specific genes identified by subtractive cDNA cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Lewy bodies contain beta-amyloid precursor proteins of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Synuclein proteins and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Diffuse Lewy body disease and progressive dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Synthetic filaments assembled from C-terminally truncated alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Low frequency of alpha-synuclein mutations in familial Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

A susceptibility locus for Parkinson's disease maps to chromosome 2p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Genetic classification of primary neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Identification of two distinct synucleins from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Lewy bodies in cerebral cortex, report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

A detergent-insoluble membrane compartment contains A beta in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The ubiquitin pathway in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The rat brain synucleins; family of proteins transiently associated with neuronal membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Synaptic and neuritic alterations during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Alpha synuclein in neurodegenerative disorders: murderer or accomplice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Purification and characterization of a novel brain-specific 14-kDa protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Copper(II)-induced self-oligomerization of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Mapping of a gene for Parkinson's disease to chromosome 4q21-q23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Oxidative damage and mitochondrial decay in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Cloning and characterization of the cDNA encoding a novel brain-specific 14-kDa protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Contribution of somal Lewy bodies to neuronal death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Genetic and environmental risk factors in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abeta1-42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

The Presence of Amyloid β-Protein in the Detergent-Insoluble Membrane Compartment of Human Neuroblastoma Cells†

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.1999.TB00552.X

10.1111/J.1750-3639.1999.TB00552.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10517509